A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02809144

Enrollment

Registered

2016-06-22

Start date

2016-04-30

Completion date

2016-11-30

Last updated

2016-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Interscalene block has been the traditional regional anesthesia for shoulder surgery and postoperative pain. However, the risk of phrenic nerve palsy and irreversible nerve injury have encouraged search for alternative methods.

Detailed description

Analyzing block effects of the lateral sagittal infraclavicular brachial plexus block(posterior and lateral chord), the investigators found it affecting all shoulder relevant nerves , except for the suprascapular and the supraclavicular nerves. Accordingly, by combining a superficial cervical plexus block, suprascapular nerve block and block of the posterior and lateral chords infraclavicularly, the investigators believe this novel combination would provide anesthesia for patients scheduled for shoulder surgery.

Interventions

PROCEDURENerve block

Nerve block: 31 ml ropivacaine 7.5 mg/ml (Lateral sagittal infraclavicular brachial plexus block) + 4 ml ropivacaine 5 mg/ml (suprascapular nerve block) + 5 ml ropivacaine 5 mg/ml (superficial cervical plexus block)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patients scheduled for shoulder surgery. * American Society of Anesthesiologist grad I-III, * 18-70 years, * BMI 20-35,

Exclusion criteria

* Pregnancy, * coagulopathy, * allergy to local anesthetics, * atrioventricular block, * peripheral neuropathy or drug-treated diabetes. * Patients using anticoagulation other than acetylsalicylic acid or dipyridamol will be excluded.

Design outcomes

Primary

Measure	Time frame	Description
The need for general anaesthesia	Intraoperatively	Investigators will record the number of patients who need to be converted to general anaesthesia

Secondary

Measure	Time frame	Description
Surgeons satisfaction with the working conditions	Intraoperatively	Graded in a) Good and b) Poor

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026